Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sambuughin, N.
Right arrow Articles by Sivakumar, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sambuughin, N.
Right arrow Articles by Sivakumar, K.
Related Collections
Right arrow All Neuromuscular Disease
Right arrow Peripheral neuropathy
Right arrow Cranial neuropathy
Right arrow All Genetics

Neurology 2003;60:506-508
© 2003 American Academy of Neurology


Brief Communications

Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene

Nyamkhishig Sambuughin, PhD, Astrid de Bantel, BS, Shona McWilliams, MS and Kumaraswamy Sivakumar, MD

From the Division of Neurology, Neuromuscular Diseases Section, Barrow Neurological Institute, Phoenix, AZ.

Address correspondence and reprint requests to Dr. K. Sivakumar, Barrow Neurological Institute, 240 W. Thomas Rd., Phoenix, AZ 85013; e-mail: ksivakumar{at}chw.edu

The molecular basis for the clinically distinct entity of deafness with Charcot-Marie-Tooth disease has not been established with certainty. The authors report deafness associated with a demyelinating neuropathy in three individuals of a family in whom a novel four–amino acid deletion in the PMP22 gene was identified. The data and review of literature suggest that in the PMP22 gene, some point mutations and small deletions in the transmembrane domain that are in close proximity to the extracellular component of the protein result in this clinically distinct entity.




This article has been cited by other articles:


Home page
NeurologyHome page
H. -J. Kim, S. H. Hong, C. -S. Ki, B. -J. Kim, J. -S. Shim, S. -H. Cho, J. -H. Park, and J. -W. Kim
A novel locus for X-linked recessive CMT with deafness and optic neuropathy maps to Xq21.32-q24
Neurology, June 14, 2005; 64(11): 1964 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. R. Aho, R. C. Wallace, A. M. Pitt, and K. Sivakumar
Charcot-Marie-Tooth Disease: Extensive Cranial Nerve Involvement on CT and MR Imaging
AJNR Am. J. Neuroradiol., March 1, 2004; 25(3): 494 - 497.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.